• Home
  • Search
  • Browse Collections
  • My Account
  • About
  • DC Network Digital Commons Network™
Skip to main content
Digital Commons at St. Mary's University St. Mary's University
  • Home
  • About
  • FAQ
  • My Account
  • STMU SITES

Home > acacollection > StuSch > biocomm > MECOFDIS

Mechanisms of Disease

 
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.

Follow

Switch View to Grid View Slideshow
 
  • ITGB1 Knockdown Alters Apoptosis and Proliferation in Ewing Sarcoma Cells by Aditi Kumar, Magdalena Saad, and Terry Jo Shackleford

    ITGB1 Knockdown Alters Apoptosis and Proliferation in Ewing Sarcoma Cells

    Aditi Kumar, Magdalena Saad, and Terry Jo Shackleford

    Integrin beta 1 (ITGB1) is an adhesion receptor that link cells to the extracellular matrix and regulates pathways involved in survival, proliferation, and migration. In order to understand its role in Ewing Sarcoma, we applied CRISPR-Cas9 with two guide RNAs to knock down ITGB1 in ES8 cells. We then assessed changes in cell growth, death, movement, and gene expression using Incucyte live-cell imaging, colony formation assays, wound healing assays, and qRT-PCR. qRT-PCR showed partial ITGB1 reduction, with ITGB1_gRNA2 producing the strongest decrease. ITGB1_gRNA2 also led to a small increase in caspase activity and a 20-30% increase in proliferation at the later time intervals. Migration remained unchanged, and colony formation varied with density but did not have statistical significance. Partial ITGB1 knockdown produced small but measurable effects on apoptosis and proliferation so ITGB1 does contribute to survival signaling in ES8 cells but may require extending imaging, improved qRT-PCR controls, and more replicates to help clarify these results.

 
 
 

Browse

  • Collections
  • Disciplines
  • Authors

Search

Advanced Search

  • Notify me via email or RSS

Author Corner

  • Author FAQ
 
Elsevier - Digital Commons

Home | About | FAQ | My Account | Accessibility Statement

Privacy Copyright